The development of a novel, artificial intelligence (AI)-generated biotechnology has the potential to transform care options ...
Shares of Masimo Co. (NASDAQ:MASI – Get Free Report) have received an average rating of “Moderate Buy” from the seven ...
A St. Louis-based clinical-stage biotechnology company developing cancer-fighting drugs has hired a new medical chief. Wugen ...
Gilero, based in Durham, is a medical device design, development and contract manufacturer that was bought in September by German-based Sanner Group. The expansion represents a $6.4 million investment ...
Apple executives discussed acquiring Masimo and installing Kiani as vice president of Medical Technologies ... and the jury’s ...
Masimo executives are back calling their consumer audio business Sound United, with a senior executive on a conference call ...
Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...
Executives said the patient monitoring company’s consumer business will likely become a discontinued operation if it is not ...
Needham analyst Michael Matson maintained a Hold rating on Masimo (MASI – Research Report) today. The company’s shares closed ...
In a report released today, Marie Thibault from BTIG maintained a Buy rating on Masimo (MASI – Research Report), with a price target of ...
Masimo (Nasdaq:MASI) shares ticked up before hours today on third-quarter results that came in ahead of the consensus ...